ArticleProceedings of the National Academy of Sciences of the United States of America2013

TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients.

Gisela Caceres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.